KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
Brad H. Rovin, Jonathan Barratt, H. Terence Cook, Irene L. Noronha, Heather N. Reich, Yusuke Suzuki, Sydney Tang, Hernán Trimarch, Jürgen Floege
Abstract
This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the International Society of Nephrology or Elsevier. Dosages, indications, and methods of use for products that are referred to in the supplement by the authors may reflect their clinical experience or may be derived from the professional literature or other clinical sources.
Topics & Concepts
MedicineGuidelineClinical PracticeNephrologyIntensive care medicineNephropathyVasculitisInternal medicineAntibodyANCA-Associated VasculitisKidney diseaseMEDLINEImmunologyMembranous nephropathyGlomerulonephritisImmunoglobulin GFamily medicineQuality of Life ResearchImmunoglobulin AKidneyEpidemiologyAlternative medicineRenal Diseases and GlomerulopathiesVasculitis and related conditionsCoagulation, Bradykinin, Polyphosphates, and Angioedema